Highlights from the Great Debates and Updates in Gastrointestinal Malignancies conference 2024
The Great Debates and Updates in Gastrointestinal Malignancies conference took place in Dallas on October 19th and 20th, 2023.
This dynamic event focused on the latest advancements in the treatment of GI tract cancers, utilizing a debate-driven format to explore both sides of current and controversial topics.
Attendees had the opportunity to engage with leading experts and industry leaders, fostering valuable networking experiences. The conference encouraged audience participation, allowing practitioners to reflect on how new developments can enhance their practices. By combining education, debate, and networking, this unique event empowered clinicians in their fight against gastrointestinal malignancies.
Healthcare professionals shared their insights on social media:
“GI oncology at Great Debates CME going strong for 20+ years with clinically relevant hot-off the press research data. Thank you for spending the weekend with us in Dallas.
Save the date for March 22-23 2025 GDGI date in NYC.”
“Special thank you to our sponsors at the Great Debates and Updates in Gasterointestinal Malignancies. We look forward to seeing you all in 2025!!!”
“Outstanding overview of systemic therapy for biliary cancers by Midhun Malla at GDUGI.
Encouraging to hear about tinengotinib showing activity in the setting of resistance to FGFR-targeted therapy.”
“Mike Gibson from VUMC Division of Hematology/Oncology kicking off Great Debates with a discussion on zolbetuximab -timely given yesterday’s FDA approval!”
“Day-2 : What a classic debate between Rachna Shroff and Milind Javle on TOPAZ-1study, emphasizing the significant OS benefits of immunotherapy in gastrointestinal cancers, highlighted how immunotherapy impacts on both survival and QOL making universal application in GI cancer. Gained fascinating new insights.”
“We may live in different states but friends forever! My former MD Anderson Cancer Center PA, Aki, Rachna Shroff, Prajnan Das, Arvind Dasari.”
“Immune checkpoint inhibitors in pMMR/MSS CRC. Yes vs. No. Debate is on fire. Kristen Ciombor and Smitha Krishnamurthi have nailed their arguments for and against respectively.”
“Terrific to see Arvind Dasari and Jason Zell debate the role of ctDNA for colorectal cancer.”
“It’s a wrap.
Another successful Great Debates and Updates in Gastrointestinal Malignancies conference. Thank you to all of our wonderful speakers, attendees and my co-chair Yelena Y. Janjigian.”
“And that’s a wrap! What a great meeting with some amazing colleagues. Arvind Dasari is a class act- honored to debate w you on stage. I learned much – including a new term ‘Pelican beak-shaped survival curves’!”
For more posts like this, visit oncodaily.com
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023